Published in Mol Gen Genet on February 01, 1987
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1990) 6.11
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother (1990) 5.81
Characterization of beta-lactamases. Antimicrob Agents Chemother (1989) 5.13
Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1989) 3.96
Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother (1988) 3.65
Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother (1993) 3.63
The region of the IncN plasmid R46 coding for resistance to beta-lactam antibiotics, streptomycin/spectinomycin and sulphonamides is closely related to antibiotic resistance segments found in IncW plasmids and in Tn21-like transposons. Nucleic Acids Res (1987) 3.54
Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1). Biochem J (1988) 3.49
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother (1992) 3.31
Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother (1990) 3.26
A comparative study of class-D beta-lactamases. Biochem J (1993) 2.68
SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60
Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother (1989) 2.44
Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2001) 2.10
Detection of plasmid-mediated beta-lactamases with DNA probes. Antimicrob Agents Chemother (1988) 1.99
Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase. Antimicrob Agents Chemother (1990) 1.92
Sequence of the PSE-1 beta-lactamase gene. Antimicrob Agents Chemother (1991) 1.81
Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons. J Bacteriol (1990) 1.60
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens. Antimicrob Agents Chemother (1990) 1.59
Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother (1991) 1.52
Cloning and expression of the imipenem-hydrolyzing beta-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother (1988) 1.50
Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother (1990) 1.36
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 1.35
Development of natural and synthetic DNA probes for OXA-2 and TEM-1 beta-lactamases. Antimicrob Agents Chemother (1987) 1.32
Oligonucleotide probes (TEM-1, OXA-1) versus isoelectric focusing in beta-lactamase characterization of 114 resistant strains. Antimicrob Agents Chemother (1988) 1.23
Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol (1994) 1.16
Molecular characterization of the class II multiresistance transposable element Tn1403 from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.14
Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics. Antimicrob Agents Chemother (1995) 1.08
Evolutionary perspectives on multiresistance beta-lactamase transposons. J Bacteriol (1989) 1.01
Plasmid-mediated ROB-1 beta-lactamase in Pasteurella multocida from a human specimen. Antimicrob Agents Chemother (1991) 0.99
Sequence and molecular characterization of the ROB-1 beta-lactamase gene from Pasteurella haemolytica. Antimicrob Agents Chemother (1991) 0.98
Structure of CARB-4 and AER-1 carbenicillin-hydrolyzing beta-lactamases. Antimicrob Agents Chemother (1998) 0.93
Molecular distribution of ROB-1 beta-lactamase in Actinobacillus pleuropneumoniae. Antimicrob Agents Chemother (1991) 0.88
Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase. Antimicrob Agents Chemother (1987) 0.83
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
A standard numbering scheme for the class A beta-lactamases. Biochem J (1991) 17.44
The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil. Trop Geogr Med (1971) 11.37
Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28
More extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1991) 11.28
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1990) 6.11
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother (1990) 5.81
Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 5.16
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother (2006) 4.88
Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol Microbiol (1992) 4.34
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother (1997) 4.20
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother (1999) 3.85
Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis (1971) 3.76
In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother (1996) 3.73
Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother (1988) 3.65
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol (1994) 3.61
Plasmid-determined resistance to tellurium compounds. J Bacteriol (1977) 3.56
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother (1996) 3.44
Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet (1975) 3.34
Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother (1985) 3.34
Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet (1974) 3.26
Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother (1990) 3.26
Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases. Antimicrob Agents Chemother (1983) 3.19
Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States. N Engl J Med (1982) 2.97
Beta-lactamases. Br Med Bull (1984) 2.90
Properties of PSE-2 beta-lactamase and genetic basis for its production in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1983) 2.82
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob Agents Chemother (2000) 2.80
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol (2001) 2.80
Transposition of Pseudomonas toluene-degrading genes and expression in Escherichia coli. Nature (1978) 2.54
Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.52
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol (1994) 2.47
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41
Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J Biol Chem (1993) 2.37
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Spread of a "Pseudomonas-specific" beta-lactamase to plasmids of enterobacteria. J Bacteriol (1982) 2.28
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother (2004) 2.27
Nucleotide sequence and phylogeny of SHV-2 beta-lactamase. Antimicrob Agents Chemother (1990) 2.26
A unitary account of the repression mechanism of arginine biosynthesis in Escherichia coli. I. The genetic evidence. J Mol Biol (1969) 2.23
An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother (1986) 2.21
Control of the argECBH cluster in Escherichia coli. Mol Gen Genet (1972) 2.18
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother (2000) 2.15
Molecular structure and interrelationships of multiresistance beta-lactamase transposons. Plasmid (1988) 2.11
beta-Lactamases and beta-lactam resistance in Escherichia coli. Antimicrob Agents Chemother (1985) 2.09
Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 2.07
Detection of plasmid-mediated beta-lactamases with DNA probes. Antimicrob Agents Chemother (1988) 1.99
Multiplex polymerase chain reaction for detection and differentiation of the microbial insecticide Bacillus thuringiensis. Appl Environ Microbiol (1993) 1.96
Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 beta-lactamase crystal structure. J Biol Chem (1990) 1.95
Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase. Antimicrob Agents Chemother (1990) 1.92
Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes. Antimicrob Agents Chemother (1993) 1.86
Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance. Antimicrob Agents Chemother (1974) 1.86
Comparative analysis of the 16S to 23S ribosomal intergenic spacer sequences of Bacillus thuringiensis strains and subspecies and of closely related species. Appl Environ Microbiol (1995) 1.82
Sequence of the PSE-1 beta-lactamase gene. Antimicrob Agents Chemother (1991) 1.81
Recombination between plasmids of incompatibility groups P-1 and P-2. J Bacteriol (1976) 1.79
Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother (1980) 1.79
Fever of undetermined origin. N Engl J Med (1973) 1.77
Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother (1991) 1.75
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrob Agents Chemother (1994) 1.70
Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 beta-lactamase of Pseudomonas aeruginosa. Gene (1991) 1.62
Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons. J Bacteriol (1990) 1.60
Ribosomal ambiguity. Cold Spring Harb Symp Quant Biol (1966) 1.60
Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother (2005) 1.60
The induction and repression of amino acid oxidation in Pseudomonas fluorescens. Biochem J (1964) 1.59
Computer-generated plots of results of antimicrobial-susceptibility tests. JAMA (1969) 1.58
Plasmid-determined resistance to boron and chromium compounds in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 1.58
Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1998) 1.57
Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol (1995) 1.55
Compatibility and molecular properties of plasmid Rms 149 in Pseudomonas aeruginosa and Escherichia coli. Plasmid (1980) 1.53
Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D beta-lactamases. Antimicrob Agents Chemother (1995) 1.52
Recent experience with bacillemia due to gram-negative organisms. J Infect Dis (1971) 1.50
Cloning and expression of the imipenem-hydrolyzing beta-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother (1988) 1.50
Mapping the gene determining ornithine transcarbamylase and its operator in Escherichia coli B. J Bacteriol (1971) 1.47
Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother (1985) 1.45
Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis (1993) 1.44
The distribution of beta-lactamase genes on plasmids found in Pseudomonas. Plasmid (1979) 1.43
Diagnosis of gonorrhea in male patients by culture of uncentrifuged first-voided urine. JAMA (1977) 1.42
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemother (1993) 1.39
Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother (1996) 1.39
Novel plasmid-mediated beta-lactamase in members of the family Enterobacteriaceae from Ohio. Antimicrob Agents Chemother (1986) 1.38
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 1.38
Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.37
Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother (1990) 1.36
Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different beta-lactamases. Antimicrob Agents Chemother (1979) 1.34
Site-saturation mutagenesis and three-dimensional modelling of ROB-1 define a substrate binding role of Ser130 in class A beta-lactamases. Protein Eng (1992) 1.34
Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother (1993) 1.34
International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34
Epidemiology of extended-spectrum beta-lactamases. Clin Infect Dis (1998) 1.33
Development of natural and synthetic DNA probes for OXA-2 and TEM-1 beta-lactamases. Antimicrob Agents Chemother (1987) 1.32
Properties of IncP-2 plasmids of Pseudomonas spp. Antimicrob Agents Chemother (1983) 1.30
Single-disk diffusion testing (Kirby-Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. J Clin Microbiol (1980) 1.24
Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med (1980) 1.21
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20